Literature DB >> 25766650

Changes in the Lémann Index Values During the First Years of Crohn's Disease.

Cyrielle Gilletta1, Maïté Lewin2, Anne Bourrier3, Isabelle Nion-Larmurier3, Sylvie Rajca3, Laurent Beaugerie3, Harry Sokol3, Benjamin Pariente4, Philippe Seksik3, Jacques Cosnes5.   

Abstract

BACKGROUND & AIMS: Stricturing or penetrating lesions develop over time in most patients with Crohn's disease. The Lémann Index indicates the degree of digestive damage at a given time in an individual. We tracked changes in Lémann Index scores in an inception cohort of patients and looked for factors associated with digestive damage.
METHODS: We studied 221 patients diagnosed with Crohn's disease from 2004 through 2011 who received 2 or 3 serial morphologic evaluations over a period of 2 to 10 years. We collected cross-sectional images and had them reviewed by a gastroenterologist and a radiologist; Lémann index scores were calculated. A value of 2 was chosen as the cut-off value for substantial transparietal damage. Factors associated with a score greater than 2 at the last evaluation and progression of index scores were identified using univariate analysis and logistic regression analyses.
RESULTS: The median index Lémann Index scores were 2.3 (interquartile range [IQR], 1.2-3.9) at first evaluation, 3.5 (IQR, 1.2-8.6) at 2 to 5 years after diagnosis, and 8.3 (IQR, 1.2-12.1) at 5 to 10 years after diagnosis. Index scores increased significantly at each stage compared with initial or previous values (P < .0001). After 73 months (IQR, 51-96 mo) of follow-up evaluation, 138 patients had a Lémann Index score greater than 2.0. The only early factor that predicted later damage was the first index value. Intestinal resection, time, and the percentage of time elapsed with a clinically active disease were associated with progressing damage.
CONCLUSIONS: Based on an analysis of patients with Crohn's disease using the Lémann Index, nearly two thirds had substantial mucosal damage 2 to 10 years after diagnosis. High Lémann index scores at the first evaluation, time, persistent clinical activity, and intestinal resection are associated with damage.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed Tomography; Inflammatory Bowel Disease; Magnetic Resonance Imaging; Surgery

Mesh:

Year:  2015        PMID: 25766650     DOI: 10.1016/j.cgh.2015.02.041

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  10 in total

Review 1.  Small Bowel Imaging: an Update.

Authors:  Jordi Rimola; Julián Panés
Journal:  Curr Gastroenterol Rep       Date:  2016-07

2.  Magnetic resonance evaluation for small bowel strictures in Crohn's disease: comparison with balloon enteroscopy.

Authors:  Kento Takenaka; Kazuo Ohtsuka; Yoshio Kitazume; Katsuyoshi Matsuoka; Toshimitsu Fujii; Masakazu Nagahori; Maiko Kimura; Tomoyuki Fujioka; Akihiro Araki; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2016-11-15       Impact factor: 7.527

Review 3.  Preventing Collateral Damage in Crohn's Disease: The Lémann Index.

Authors:  Gionata Fiorino; Cristiana Bonifacio; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  J Crohns Colitis       Date:  2016-01-07       Impact factor: 9.071

4.  The Cost of Crohn's Disease: Varied Health Care Expenditure Patterns Across Distinct Disease Trajectories.

Authors:  Bhavana B Rao; Benjamin H Click; Ioannis E Koutroubakis; Claudia Ramos Rivers; Miguel Regueiro; Jason Swoger; Marc Schwartz; Jana Hashash; Arthur Barrie; Michael A Dunn; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2017-01       Impact factor: 5.325

Review 5.  Impact of therapies on bowel damage in Crohn's disease.

Authors:  Gionata Fiorino; Cristiana Bonifacio; Mariangela Allocca; Silvio Danese
Journal:  United European Gastroenterol J       Date:  2020-02-20       Impact factor: 4.623

Review 6.  A review of magnetic resonance enterography-based indices for quantification of Crohn's disease inflammation.

Authors:  Noa Rozendorn; Marianne Michal Amitai; Rami Abraham Eliakim; Uri Kopylov; Eyal Klang
Journal:  Therap Adv Gastroenterol       Date:  2018-04-13       Impact factor: 4.409

Review 7.  Treat-to-target in Crohn's disease: Will transmural healing become a therapeutic endpoint?

Authors:  Elena Daniela Serban
Journal:  World J Clin Cases       Date:  2018-10-26       Impact factor: 1.337

8.  Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.

Authors:  Joana Torres; Flavio Caprioli; Konstantinos H Katsanos; Triana Lobatón; Dejan Micic; Marco Zerôncio; Gert Van Assche; James C Lee; James O Lindsay; David T Rubin; Remo Panaccione; Jean-Frédéric Colombel
Journal:  J Crohns Colitis       Date:  2016-06-09       Impact factor: 9.071

9.  Bowel Damage at Diagnosis Using the Lémann Index Score in Saudi Arabian Patients With Crohn's Disease.

Authors:  Hajar Halawani; Ahmed Abduljabbar; Mohammad Wazzan; Dalia Abdulmonem Hashem; Cedric Baumann; Amandine Luc; Laurent Peyrin-Biroulet; Omar I Saadah; Mahmoud Mosli
Journal:  Cureus       Date:  2020-10-12

Review 10.  Diagnosis and natural history of preclinical and early inflammatory bowel disease.

Authors:  Iago Rodríguez-Lago; Yamile Zabana; Manuel Barreiro-de Acosta
Journal:  Ann Gastroenterol       Date:  2020-06-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.